
Sign up to save your podcasts
Or
Interview with David W. Hutton, PhD, author of Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema. Hosted by Neil Bressler, MD.
4
55 ratings
Interview with David W. Hutton, PhD, author of Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema. Hosted by Neil Bressler, MD.
136 Listeners
323 Listeners
500 Listeners
43 Listeners
38 Listeners
17 Listeners
8 Listeners
16 Listeners
18 Listeners
13 Listeners
11 Listeners
6 Listeners
9 Listeners
20 Listeners
88 Listeners
5 Listeners
30 Listeners
14 Listeners
6 Listeners
107 Listeners
19 Listeners
8 Listeners
2 Listeners
21 Listeners
10 Listeners
51 Listeners
10 Listeners
2 Listeners
163 Listeners
18 Listeners
17 Listeners
16 Listeners
0 Listeners